ACCOUNTS - Final Accounts

ACCOUNTS - Final Accounts

BELGRAVE BLOODSTOCK LIMITED - Company Information

Print Friendly Version

Caseware UK (AP4) 2022.0.179 2022.0.179 2022-12-312022-12-31true2022-01-01trueNo description of principal activity00true 06778682 2021-12-31 06778682 2022-01-01 2022-12-31 06778682 2021-01-01 2021-12-31 06778682 2022-12-31 06778682 c:Director1 2022-01-01 2022-12-31 06778682 d:CurrentFinancialInstruments 2022-12-31 06778682 d:CurrentFinancialInstruments 2021-12-31 06778682 c:EntityHasNeverTraded 2022-01-01 2022-12-31 06778682 c:FRS102 2022-01-01 2022-12-31 06778682 c:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 06778682 c:FullAccounts 2022-01-01 2022-12-31 06778682 c:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 iso4217:GBP xbrli:pure

Registered number: 06778682










BELGRAVE BLOODSTOCK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2022
 
BELGRAVE BLOODSTOCK LIMITED
REGISTERED NUMBER: 06778682

BALANCE SHEET
AS AT 31 DECEMBER 2022

2022
2021
Note
£
£

Current assets
  

Debtors: amounts falling due within one year
 3 
2
2

  
2
2

Total assets less current liabilities
  
 
 
2
 
 
2

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
  
2
2

  
2
2


For the year ended 31 December 2022 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on: 

N Ryder
Director

Date: 13 September 2023

 
BELGRAVE BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022

1.


General information

Belgrave Bloodstock is a private company limited by share capital and incorporated in England and Wales. 
The address of the registered office is 2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB.
The company is dormant and has not traded during the year or the preceding financial year.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.


3.


Debtors

2022
2021
£
£


Called up share capital not paid
2
2

2
2